Turkish immigrant Oguzhan Atay started the company in 2016 with a focus on prenatal testing. Now, he’s expanding to cancer ...

Round-the-clock fetal monitoring leads to unnecessary C-sections. But it’s used in nearly every birth because of business and ...

A test analyzing fetal DNA found in a pregnant woman’s blood proved much more accurate in screening for Down syndrome and another chromosomal disorder than the now-standard blood test, a new study has ...

A simple blood test is transforming the world of prenatal screening, offering women a risk-free way to learn about fetal abnormalities early in pregnancy. Already, the new test has drastically reduced ...

Molecular diagnostics firm BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw ...

The Committee on Genetics of the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine has released an opinion on the "advantages and limitations" of ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

Non-invasive prenatal testing (NIPT) can tell a lot about your baby long before birth. It looks at your baby’s genetic information through your blood to check for certain conditions early in pregnancy ...

The NIPT (noninvasive prenatal testing) is a genetic test performed on pregnant women, in order to detect fetal chromosomal aneuploidies. It is based upon the testing of cell-free fetal DNA (cf-fDNA) ...

NEW YORK (Reuters Health) - Normally, parents who want to know the sex of their baby before it's born find out through ultrasound done in the second trimester. A blood test that can be done early in ...

Rising demand for early genetic screenings, technological advancements, and increased awareness are key growth drivers. With ...